August 11, 2022 — Advanced Technology International (ATI) and TechConnect today announced 25 finalists who will pitch on September 28, 2022 at Defense TechConnect Innovation Summit for $200,000 in non-dilutive awards. These candidates receive membership from four consortia with a combined $50B in federal contracting authority including: Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction Consortium (CWMD), Medical Technology Enterprise Consortium (MTEC), and Senior Healthcare Innovation Consortium (SHIC).
“Whether for civilian national security in facing epidemics, as we saw with consortia-led COVID-19 response, or for the warfighter on the battlefield or visiting the VA, medical innovation remains a critical priority for our nation,” said Matthew Laudon, Vice President – TechConnect Division, ATI. “The Medical Innovation Challenge finalists represent top solutions, out of hundreds of innovators, that can and will change our world for the better. Thank you to our nation’s four leading medtech consortia who identify, accelerate and fund breakthrough medical innovations for the protection of us all. Come meet their leadership and hear these innovators pitch this fall. We have a seat waiting for you!”
Challenge finalists represent health and biotech innovation with dual use for civilian and national security applications, especially in the areas of devices and sensors, digital and hardware, therapeutics and treatments, and materials and manufacturing. All have at least achieved prototype status and 26% have proven manufacturability.
“Innovation without a client is just novelty, and the consortium model ensures that the nation’s cutting-edge innovation finds its way into the most powerful and impactful client in the world: our federal government,” said Phil Gisi, Co-Founder of Senior Healthcare Innovation Consortium (SHIC). “We eagerly await pitch presentations this fall and the chance to meet these impressive finalists who we know will have a profound impact on our world in the years to come.”
Finalists include:
Darwin Biosciences, Inc.
Eclipxe
Ionica Sciences
Kowa, Inc.
Lab11 Therapeutics, Inc.
Limax Biosciences, Inc.
Livivos, Inc.
Luna Labs USA, LLC
Matregenix
McGill University Health Center
Nakamir, Inc.
Novaurum Bioscience
Pockit Diagnostics, Ltd
Rhaeos, Inc.
Ridgeline Therapeutics
Rubitection
SafeBeat Rx
Sana Health, Inc.
Sense Neuro Diagnostics
Sonogen Medical, Inc.
StataDX
Symphony Biosciences
Tao Treasures LLC
Teledyne FLIR Detection
XSurgical, Inc.
“Prototype advancement of medical technology will undoubtedly have a profound impact on the capabilities that we are able to provide far forward in a military setting. Through TechConnect, the Medical Technology Enterprise Consortium (MTEC) is able to showcase some of its innovative member companies to the broader medical ecosystem, hopefully resulting in further collaboration and investment to best serve our U.S. Warfighters,” said Lauren Palestrini, Ph.D., Director of Research, MTEC.
For more information about this Challenge or to register to attend, visit: https://events.techconnect.org/DTCFall/medical_innovation_challenge/.